13F Pro

SEC Form 4 reporting owner

Valantine Hannah

Valantine Hannah has filed 16 Form 4 transactions reported between February 27, 2026 and July 16, 2026, as a reporting owner of CareDx, Inc., Director of BridgeBio Pharma, Inc. and Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Name as filed: Valantine Hannah

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.2M
6 lines
Companies
3
with Form 4 filings
Latest transaction
Jul 16, 2026
transaction date

Roles and reported holdings

  • CDNACareDx, Inc.
    Jun 12, 2026 – Jul 16, 2026

    Reporting owner

    Held directly36,686 sh as of Jul 16, 2026 · Form 4

    24 months: $1.3M sold

  • BBIOBridgeBio Pharma, Inc.
    Feb 27, 2026 – Jun 23, 2026

    Director

    Held directly9,259 sh as of Jun 23, 2026 · Form 4

    24 months: $1.9M sold

  • PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Jun 3, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 16 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 16, 2026CDNAOpen-market saleCode S · direct100$4K@ $36.55Form 4
Jul 16, 2026CDNAOpen-market saleCode S · direct28,679$1.0M@ $36.14Form 4
Jul 16, 2026CDNAOption exerciseCode M · direct5,125$41K@ $7.96Form 4
Jul 16, 2026CDNAOption exerciseCode M · direct16,048$228K@ $14.19Form 4
Jul 16, 2026CDNAOption exerciseCode M · direct7,606$156K@ $20.56Form 4
Jun 23, 2026BBIODirectorOpen-market saleCode S · directAlso reported by Cook Jennifer E.2,196$151K@ $68.57Form 4
Jun 22, 2026BBIODirectorGrant or awardCode A · direct5,277—Form 4
Jun 22, 2026BBIODirectorOption exerciseCode M · direct2,808$117K@ $41.73Form 4
Jun 22, 2026BBIODirectorGrant or awardCode A · direct3,990—Form 4
Jun 15, 2026CDNAOpen-market saleCode S · direct12,103$280K@ $23.11Form 4
Jun 12, 2026CDNAGrant or awardCode A · direct9,795—Form 4
Jun 3, 2026PACBDirectorGrant or awardCode A · direct223,492—Form 4
Mar 10, 2026BBIODirectorOption exerciseCode M · direct8,671$237K@ $27.36Form 4
Feb 27, 2026BBIODirectorOpen-market saleCode S · direct10,900$739K@ $67.84Form 4
Feb 27, 2026BBIODirectorOpen-market saleCode S · direct14,584$978K@ $67.08Form 4
Feb 27, 2026BBIODirectorOption exerciseCode M · direct25,484$1.2M@ $48.45Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.